SCHEMBL3274608

SCHEMBL3274608

CC(C)[SiH](C(C)C)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1091584 1.00 LMNA (0.33) LMNA
SCHEMBL449440 0.78
SCHEMBL5613057 0.69 LMNA (0.38) LMNA
SCHEMBL28565002 0.69 LMNA (0.38) LMNA
SCHEMBL16238795 0.69 LMNA (0.38) LMNA
Perflenapent SCHEMBL8195291 0.69 LMNA (0.57) LMNA
Perflexane SCHEMBL6860804 0.69 LMNA (0.57) LMNA
SCHEMBL6449825 0.69 LMNA (0.57) LMNA
Perflenapent SCHEMBL10496510 0.65 LMNA (0.53) LMNA
Perflexane SCHEMBL7507426 0.65 LMNA (0.61) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11845105-B2 Soft plasma polymerization process for a mechanically durable superhydrophobic nanostructured coating MOLECULAR PLASMA GROUP SA (LU) 2023-12-19 US disclosed
EP-4289520-A2 SOFT PLASMA POLYMERIZATION PROCESS FOR A MECHANICALLY DURABLE SUPERHYDROPHOBIC NANOSTRUCTURED COATING Molecular Plasma Group SA (LU) 2023-12-13 EP disclosed
EP-3446793-B1 SOFT PLASMA POLYMERIZATION PROCESS FOR A MECHANICALLY DURABLE SUPERHYDROPHOBIC NANOSTRUCTURED COATING MOLECULAR PLASMA GROUP SA (LU) 2023-10-04 EP disclosed
US-20210086226-A1 SOFT PLASMA POLYMERIZATION PROCESS FOR A MECHANICALLY DURABLE SUPERHYDROPHOBIC NANOSTRUCTURED COATING MOLECULAR PLASMA GROUP SA (LU) 2021-03-25 US disclosed
EP-2809453-B1 SUPERAMPHIPHOBIC SURFACES BY ATMOSPHERIC PLASMA POLYMERIZATION CT DE RECH PUBLIC HENRI TUDOR (LU) 2016-11-02 EP disclosed
US-9464195-B2 Superamphiphobic surfaces by atmospheric plasma polymerization CENTRE DE RECHERCHE PUBLIC HENRI TUDOR (LU) 2016-10-11 US disclosed
US-20140342103-A1 SUPERAMPHIPHOBIC SURFACES BY ATMOSPHERIC PLASMA POLYMERIZATION CENTRE DE RECHERCHE PUBLIC HENRI TUDOR (LU) 2014-11-20 US disclosed
EP-2762226-A1 Hybrid coating and method to obtain such coating Centre de Recherche Public Henri Tudor (LU) 2014-08-06 EP disclosed
US-20100087634-A1 Fluorous Oligonucleotide Reagents and Affinity Purification of Oligonucleotides BERRY & ASSOCIATES, INC. (US) 2010-04-08 US disclosed
EP-1831238-A2 FLUOROUS OLIGONUCLEOTIDE REAGENTS AND AFFINITY PURIFICATION OF OLIGONUCLEOTIDES Berry & Associates , Inc. (US) 2007-09-12 EP disclosed
EP-1404687-B1 FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS UNIV PITTSBURGH (US) 2006-12-27 EP disclosed
US-20060178507-A1 Fluorous oligonucleotide reagents and affinity purification of oligonucleotides BERRY & ASSOCIATES, INC. 2006-08-10 US disclosed
WO-2006081035-A2 FLUOROUS OLIGONUCLEOTIDE REAGENTS AND AFFINITY PURIFICATION OF OLIGONUCLEOTIDES BERRY & ASSOCIATES, INC. (US) 2006-08-03 WO disclosed
US-6897331-B2 Fluorous triphase and other multiphase systems UNIVERSITY OF PITTSBURGH (US) 2005-05-24 US disclosed
EP-1404687-A4 FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS UNIV PITTSBURGH (US) 2004-10-27 EP disclosed
US-6734318-B2 FLUOROUS TRIPHASE AND THER MULTIPHASE SYSTEMS FOR EFFECTING REACTIONS AND/OR SEPARATION UNIVERSITY OF PITTSBURGH 2004-05-11 US disclosed
EP-1404687-A2 FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS UNIVERSITY OF PITTSBURGH (US) 2004-04-07 EP disclosed
US-20030125590-A1 Fluorous triphase and other multiphase systems NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-07-03 US disclosed
US-20030078444-A1 Fluorous triphase and other multiphase systems NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-04-24 US disclosed
WO-2002100802-A2 FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS UNIVERSITY OF PITTSBURGH (US) 2002-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060178507-A1 Fluorous oligonucleotide reagents and affinity purification of oligonucleotides DCLRE1B, POLM, FBL LMNA 3788/4885
US-20100087634-A1 Fluorous Oligonucleotide Reagents and Affinity Purification of Oligonucleotides DCLRE1B, POLM, FBL LMNA 3788/4885
US-20030078444-A1 Fluorous triphase and other multiphase systems NAF1, SLC29A1, PFAS LMNA 4066/4885
US-20030125590-A1 Fluorous triphase and other multiphase systems DDT, CNDP2, PFAS LMNA 4409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.